Experimental medicine approach linking brain and peripheral immune mechanisms mediating sickness behaviours in people with rheumatoid arthritis

连接大脑和外周免疫机制介导类风湿性关节炎患者疾病行为的实验医学方法

基本信息

  • 批准号:
    MR/S035753/1
  • 负责人:
  • 金额:
    $ 153.19万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2019
  • 资助国家:
    英国
  • 起止时间:
    2019 至 无数据
  • 项目状态:
    未结题

项目摘要

Sickness behaviours - including mood change and fatigue - that occur in people with immune-mediated inflammatory disorders (IMIDs) such as rheumatoid arthritis (RA) are a major unmet clinical need. Behaviours of this kind have a significant additional negative impact on prognosis, therapeutic response and outcomes. Importantly, they are consistently among the most commanding of patients' concerns. Therapeutic progress in this area requires a more profound understanding of the mechanisms underpinning the symptoms Here we propose to use an exquisitely specific intervention of proven benefit in RA, targeting TNF, to leverage a mechanistic understanding of the peripheral immune to brain communications that drive sickness behaviour. We will combine the administration of a clinically indicated therapy with highly innovative neuroimaging technologies to obtain mechanistic data in humans that has hitherto only been available in animal studies. The proposal will build on a small number of prior studies that have used neuroimaging to show abnormal brain pathways in the context of IMIDs such as RA and changes in these neuroimaging parameters following TNF inhibition. A putative mechanism linking peripheral inflammatory proteins to sickness behaviour, implicated by extensive pre-clinical and animal studies, is monocyte ingress to the brain and subsequent neural change effected by monocyte-derived TNF, most notably via glutamatergic action. Thus using ultra high-field (7T) MRI and MRS alongside innovative SPECT-CT to measure CNS infiltration by circulating labelled monocytes, we will test the following hypotheses: i) Anti-TNF therapy will effect changes in brain network connectivity and glutamate quantification in the brain.ii) RA patients will show changes in brain network connectivity and glutamate quantification correlated with sickness behaviours.iii) RA patients will show changes in monocyte infiltration to the brain that are correlated with sickness behaviours.These imaging endpoints (plus secondary cognitive-behavioural, clinical and peripheral immune endpoints) will be measured at baseline and 4 weeks later in up to 50 patients with RA, randomised 1:1 to treatment with anti-TNF antibody or placebo infusion. The baseline data will allow us to test the two key hypotheses of peripheral monocyte infiltration and glutamatergic excitoxicity as mechanisms contributing to sickness behaviour. TNF inhibitor administration will address our third hypothesis.Together this study will provide insight to the mechanisms that sub-serve sickness behaviours, and thereby new tools and targets to support future development of innovative drug treatments for such behaviours in RA and other IMIDs.
疾病行为-包括情绪变化和疲劳-发生在免疫介导的炎症性疾病(IMID),如类风湿性关节炎(RA)的人是一个主要的未满足的临床需求。这种行为对预后、治疗反应和结果具有显著的额外负面影响。重要的是,它们始终是患者最关心的问题之一。在这一领域的治疗进展需要更深刻的理解的机制的基础症状在这里,我们建议使用一个精致的特定的干预证明在类风湿关节炎的好处,靶向肿瘤坏死因子,利用机械的理解外周免疫大脑通信驱动疾病的行为。我们将联合收割机与高度创新的神经影像学技术相结合,以获得迄今为止仅在动物研究中获得的人体机制数据。该提案将建立在少量先前研究的基础上,这些研究使用神经成像来显示IMID(如RA)背景下的异常脑通路以及TNF抑制后这些神经成像参数的变化。广泛的临床前和动物研究表明,一种将外周炎性蛋白与疾病行为联系起来的假定机制是单核细胞进入大脑,随后受单核细胞衍生的TNF影响的神经变化,最明显的是通过神经元能作用。因此,使用超高场(7 T)MRI和MRS以及创新的SPECT-CT来测量循环标记单核细胞的CNS浸润,我们将检验以下假设:i)抗TNF治疗将影响脑网络连接和脑中谷氨酸定量的变化。ii)RA患者将显示与疾病行为相关的脑网络连接和谷氨酸定量的变化。这些影像学终点(加上次要认知行为、临床和外周免疫终点)将在基线和4周后在多达50名RA患者中进行测量,这些患者以1:1的比例随机接受抗TNF抗体或安慰剂输注治疗。基线数据将使我们能够测试两个关键的假设,外周单核细胞浸润和神经元兴奋毒性的机制有助于疾病的行为。TNF抑制剂管理将解决我们的第三个hypothesis.Together,这项研究将提供深入了解的机制,subserve疾病的行为,从而新的工具和目标,以支持未来的开发创新的药物治疗类风湿关节炎和其他IMID的行为。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Delirium and the risk of developing dementia: a cohort study of 12 949 patients.
Reduced circulating BMP9 and pBMP10 in hospitalized COVID-19 patients.
  • DOI:
    10.1002/pul2.12192
  • 发表时间:
    2023-01
  • 期刊:
  • 影响因子:
    2.6
  • 作者:
    Dunmore, Benjamin J.;Upton, Paul D.;Auckland, Kate;Samanta, Romit J.;Lyons, Paul A.;Smith, Kenneth G. C.;Graf, Stefan W.;Summers, Charlotte;Morrell, Nicholas
  • 通讯作者:
    Morrell, Nicholas
Peripheral inflammation is associated with alterations in brain biochemistry and mood: evidence from in vivo proton magnetic resonance spectroscopy study
周围炎症与大脑生化和情绪的改变有关:来自体内质子磁共振波谱研究的证据
  • DOI:
    10.1515/pac-2022-1119
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    1.8
  • 作者:
    Mumuni A
  • 通讯作者:
    Mumuni A
Regulation of ICAM-1 in human neutrophils
人中性粒细胞中 ICAM-1 的调节
  • DOI:
    10.17863/cam.107511
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Farahi N
  • 通讯作者:
    Farahi N
Cognitive Function in People With Familial Risk of Depression.
有家族抑郁风险的人的认知功能。
  • DOI:
    10.1001/jamapsychiatry.2023.0716
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    25.8
  • 作者:
    Cullen B
  • 通讯作者:
    Cullen B
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jonathan Cavanagh其他文献

Brain mapping inflammatory-arthritis-related fatigue in the pursuit of novel therapeutics
在追求新型治疗方法的过程中对与炎症性关节炎相关的疲劳进行大脑绘图
  • DOI:
    10.1016/s2665-9913(23)00007-3
  • 发表时间:
    2023-02-01
  • 期刊:
  • 影响因子:
    16.400
  • 作者:
    Kristian Stefanov;Salim Al-Wasity;Joel T Parkinson;Gordon D Waiter;Jonathan Cavanagh;Neil Basu
  • 通讯作者:
    Neil Basu
Neurocomputational Predictors of Response to Computerised CBT in Depression
  • DOI:
    10.1016/j.biopsych.2023.02.149
  • 发表时间:
    2023-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Filippo Queirazza;Rajeev Krishnadas;Douglas Steele;Jonathan Cavanagh;Marios Philiastides
  • 通讯作者:
    Marios Philiastides
Does a history of depression actually mediate smoking‐related pain? Findings from a cross‐sectional general population‐based study
抑郁症史真的会介导与吸烟相关的疼痛吗?一项基于一般人群的横断面研究的结果?
  • DOI:
    10.1002/j.1532-2149.2014.00470.x
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    3.6
  • 作者:
    O. V. Hecke;N. Torrance;L. Cochrane;Jonathan Cavanagh;Peter T. Donnan;S. Padmanabhan;D. Porteous;L. Hocking;Blair H. Smith
  • 通讯作者:
    Blair H. Smith
Immune-related gene expression significantly differs between depression cases and controls without increased CRP
  • DOI:
    10.1016/j.bbi.2022.07.110
  • 发表时间:
    2022-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Luca Sforzini;Annamaria Cattaneo;Clarissa Ferrari;Lorinda Turner;Nicole Mariani;Daniela Enache;Caitlin Hastings;Giulia Lombardo;Anna P. McLaughlin;Maria A. Nettis;Naghmeh Nikkheslat;Courtney Worrell;Zuzanna Zajkowska;Melisa Kose;Nadia Cattane;Nicola Lopizzo;Monica Mazzelli;Linda Pointon;Philip J. Cowen;Jonathan Cavanagh
  • 通讯作者:
    Jonathan Cavanagh
Venlafaxine alters microvascular perfusion, [<sup>123</sup>I]-beta-CIT binding and BDI scores in flushing postmenopausal women
  • DOI:
    10.1016/j.maturitas.2013.12.003
  • 发表时间:
    2014-03-01
  • 期刊:
  • 影响因子:
  • 作者:
    Jenifer Sassarini;Rajeev Krishnadas;Jonathan Cavanagh;Alice Nicol;Sally L. Pimlott;William Ferrell;Mary Ann Lumsden
  • 通讯作者:
    Mary Ann Lumsden

Jonathan Cavanagh的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jonathan Cavanagh', 18)}}的其他基金

Evaluating the role of IL-17A as an orchestrator of peripheral-central cross talk in depressive symptoms
评估 IL-17A 作为抑郁症状中外周-中枢串扰协调者的作用
  • 批准号:
    MR/Z503988/1
  • 财政年份:
    2024
  • 资助金额:
    $ 153.19万
  • 项目类别:
    Research Grant

相似国自然基金

Chinese Journal of Integrative Medicine
  • 批准号:
    81224004
  • 批准年份:
    2012
  • 资助金额:
    24.0 万元
  • 项目类别:
    专项基金项目
基于新生血管显像研究MSC治疗缺血性脑血管病的转化医学关键问题
  • 批准号:
    81171370
  • 批准年份:
    2011
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
基于循证医学本体论的临床元数据语言研究
  • 批准号:
    30972549
  • 批准年份:
    2009
  • 资助金额:
    24.0 万元
  • 项目类别:
    面上项目
岭南瑶区几种瑶族抗肝炎植物药的化学成分及生物活性研究
  • 批准号:
    20772047
  • 批准年份:
    2007
  • 资助金额:
    28.0 万元
  • 项目类别:
    面上项目

相似海外基金

The Musicality, Hearing and Genetics ("MyHearingG") Project: Experimental, epidemiological, and genomics techniques to explore the role of musicality in hearing health
音乐性、听力和遗传学(“MyHearingG”)项目:通过实验、流行病学和基因组学技术探索音乐性在听力健康中的作用
  • 批准号:
    10731677
  • 财政年份:
    2023
  • 资助金额:
    $ 153.19万
  • 项目类别:
Integrated experimental and computational approach for accurate patient-specific vascular embolization
用于准确的患者特异性血管栓塞的综合实验和计算方法
  • 批准号:
    10724852
  • 财政年份:
    2023
  • 资助金额:
    $ 153.19万
  • 项目类别:
Extending experimental evolutionary game theory in cancer in vivo to enable clinical translation: integrating spatio-temporal dynamics using mathematical modeling
扩展癌症体内实验进化博弈论以实现临床转化:使用数学建模整合时空动力学
  • 批准号:
    10662098
  • 财政年份:
    2023
  • 资助金额:
    $ 153.19万
  • 项目类别:
An Experimental Medicine Approach for the Mechanistic Understanding of Cocaine Use Disorder: Reinforcer Pathology
用于理解可卡因使用障碍机制的实验医学方法:强化病理学
  • 批准号:
    10454007
  • 财政年份:
    2022
  • 资助金额:
    $ 153.19万
  • 项目类别:
An Experimental Medicine Approach for the Mechanistic Understanding of Cocaine Use Disorder: Reinforcer Pathology
用于理解可卡因使用障碍机制的实验医学方法:强化病理学
  • 批准号:
    10661032
  • 财政年份:
    2022
  • 资助金额:
    $ 153.19万
  • 项目类别:
An Experimental Approach to Emotion Regulation: Investigating Rumination, Cognitive Control, and Maladaptive Behaviors.
情绪调节的实验方法:研究反刍、认知控制和适应不良行为。
  • 批准号:
    10203027
  • 财政年份:
    2021
  • 资助金额:
    $ 153.19万
  • 项目类别:
A pan-cancer atlas of driver mutations in >100,000 patients based on a hypothesis-driven combined computational and experimental approach
基于假设驱动的计算和实验相结合的方法,绘制了超过 100,000 名患者的驱动突变泛癌图谱
  • 批准号:
    10620844
  • 财政年份:
    2021
  • 资助金额:
    $ 153.19万
  • 项目类别:
A pan-cancer atlas of driver mutations in >100,000 patients based on a hypothesis-driven combined computational and experimental approach
基于假设驱动的计算和实验相结合的方法,绘制了超过 100,000 名患者的驱动突变泛癌图谱
  • 批准号:
    10276520
  • 财政年份:
    2021
  • 资助金额:
    $ 153.19万
  • 项目类别:
A pan-cancer atlas of driver mutations in >100,000 patients based on a hypothesis-driven combined computational and experimental approach
基于假设驱动的计算和实验相结合的方法,绘制了超过 100,000 名患者的驱动突变泛癌图谱
  • 批准号:
    10617428
  • 财政年份:
    2021
  • 资助金额:
    $ 153.19万
  • 项目类别:
Cost-effectiveness of Pharmacogenomic-guided (PGX) Approach to Warfarin Therapy among Patients diagnosed with Atrial Fibrillation: Experimental Evidence from Ontario
药物基因组学指导 (PGX) 方法对诊断为心房颤动的患者进行华法林治疗的成本效益:来自安大略省的实验证据
  • 批准号:
    386422
  • 财政年份:
    2017
  • 资助金额:
    $ 153.19万
  • 项目类别:
    Studentship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了